|
|
Volumn 15, Issue 10, 2014, Pages e422-
|
|
Lymphocytes prognostic in breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
BREAST NEOPLASMS;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
MORTALITY;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REPRODUCIBILITY;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS, PHASE III AS TOPIC;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LYMPHOCYTES, TUMOR-INFILTRATING;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REPRODUCIBILITY OF RESULTS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84922391814
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/s1470-2045(14)70369-9 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|